In 2023, Canada's tetracycline imports were valued at $8.570 million. The forecast from 2024 to 2028 indicates a gradual annual decrease in import value: $8.469 million in 2024, $8.365 million in 2025, $8.262 million in 2026, $8.162 million in 2027, and $8.063 million in 2028. This signifies a steady declining trend in the tetracycline import market in Canada over the forecasted period.
Year-on-Year Variations:
- The import value is expected to decrease annually by approximately 1.2% from 2024 to 2028.
In terms of future trends, monitoring global pharmaceutical supply chain disruptions, changes in Canada's healthcare policies, and shifts in antibiotic demand would be crucial. Additionally, factors such as local production capabilities and competition from alternative antibiotics could further impact import trends.
